2 results match your criteria: "School of Medicine in Tongji University Shanghai 200072[Affiliation]"
Erratum: Silencing miR-454 suppresses cell proliferation, migration and invasion via directly targeting MECP2 in renal cell carcinoma.
Am J Transl Res
November 2020
Department of Urology, Shanghai Tenth People's Hospital, School of Medicine in Tongji University Shanghai 200072, China.
[This corrects the article on p. 4277 in vol. 12, PMID: 32913504.
View Article and Find Full Text PDFSilencing miR-454 suppresses cell proliferation, migration and invasion via directly targeting MECP2 in renal cell carcinoma.
Am J Transl Res
August 2020
Department of Urology, Shanghai Tenth People's Hospital, School of Medicine in Tongji University Shanghai 200072, China.
Renal cell cancer (RCC) is one of the most common malignant tumors of the urinary system. MicroRNA-454 (miR-454) has been reported to play an important role in various cancer progressions, such as hepatocellular carcinoma, breast cancer and glioblastoma. Nevertheless, its effect on RCC still remains unknown.
View Article and Find Full Text PDF